Encompass Health Revenue Growth Rates (EHC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Encompass Health Corporation  (NYSE: EHC)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

EHC's Revenue Growth by Quarter and Year

Encompass Health's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/EHC/growth
https://api.csimarket.com/api/v1/companies/EHC/fundamentals
https://api.csimarket.com/api/v1/companies/EHC/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
EHC Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 1,609.50
2nd Quarter June 1,597.40
1st Quarter March 1,586.60
FY 4,793.50

EHCs Annual Revenue
Encompass Health's Revenue in the fiscal year 2025 $ 5,935.20 millions
Encompass Health's Revenue in the fiscal year 2024 $ 5,373.20 millions
Encompass Health's Revenue in the fiscal year 2023 $ 4,801.20 millions
Encompass Health's Revenue in the fiscal year 2022 $ 4,348.60 millions
Encompass Health's Revenue in the fiscal year 2021 $ 5,121.60 millions




EHC Revenue third quarter 2026 Y/Y Growth Comment
Encompass Health Corporation achieved in the third quarter 2026, above Company average Revenue improvement of 8.93% year on year, to $ 1,609.50 millions.

Looking into third quarter 2026 results within Healthcare Facilities industry 24 other companies have achieved higher Revenue growth. While Encompass Health Corporation' s Revenue increase of 8.93% ranks overall at the positon no. 2272 in the third quarter 2026.


EHC Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 8.93 %
2nd Quarter June 9.58 %
1st Quarter March 9.01 %
FY   -

Financial Statements
Encompass Health's third quarter 2026 Revenue $ 1,609.50 millions EHC's Income Statement
Encompass Health's third quarter 2025 Revenue $ 1,477.50 millions Quarterly EHC's Income Statement


EHC Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 0.76 %
2nd Quarter June 0.68 %
1st Quarter March 2.72 %
FY (Year on Year)   -


Back to EHC Growth rate Comparisons >> Back to EHC Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #25
Healthcare Sector #331
Overall #2272

Revenue Y/Y Growth Statistics
High Average Low
31.46 % 8.11 % -23.46 %
(Dec 31 2015)   (Jun 30 2023)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #25
Healthcare Sector #331
Overall #2272
Revenue Y/Y Growth Statistics
High Average Low
31.46 % 8.11 % -23.46 %
(Dec 31 2015)   (Jun 30 2023)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Encompass Health's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
95.03 % 0.76 % -100 %
(Mar 31 2023)  


EHC's III. Quarter Q/Q Revenue Comment
Encompass Health Corporation achieved in the III. Quarter 2026 below company average Revenue growth of 0.76% quarter on quarter, to $ 1,609.50 millions.

Within Healthcare Facilities industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Encompass Health's Revenue growth quarter on quarter, overall rank is 1673.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #19
Healthcare Sector #224
Overall #1673
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #19
Healthcare Sector #224
Overall #1673
Revenue Q/Q Growth Statistics
High Average Low
95.03 % 0.76 % -100 %
(Mar 31 2023)  


EHC's III. Quarter Q/Q Revenue Comment
Encompass Health Corporation achieved in the III. Quarter 2026 below company average Revenue growth of 0.76% quarter on quarter, to $ 1,609.50 millions.

Within Healthcare Facilities industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Encompass Health's Revenue growth quarter on quarter, overall rank is 1673.


Encompass Health's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 6,338.10
Y / Y Revenue Growth (TTM) 9.36 %
Year on Year Revenue Growth Overall Ranking # 1335
Seqeuential Revenue Change (TTM) 2.13 %
Seq. Revenue Growth (TTM) Overall Ranking # 2333


Cumulative Revenue growth Comment
Assuming the Encompass Health's fiscal year would have ended in Sep 30 2026, Encompass Health would have reprted above average annual Revenue improvement of 9.36% year on year, of $ 6,338 millions.
This marks a slow-down of the companys growth trends and from the 9.47% growth in Jun 30 2026.

In the Healthcare sector 228 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 402 to 1335.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 25
Healthcare Sector # 229
Overall # 1335

Revenue TTM Y/Y Growth Statistics
High Average Low
31.46 %
 8.11 %
-23.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 336
S&P 500 # 2333
Cumulative Revenue growth Comment
Assuming the Encompass Health's fiscal year would have ended in Sep 30 2026, Encompass Health would have reprted above average annual Revenue improvement of 9.36% year on year, of $ 6,338 millions.
This marks a slow-down of the companys growth trends and from the 9.47% growth in Jun 30 2026.

In the Healthcare sector 228 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 402 to 1335.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 25
Healthcare Sector # 229
Overall # 1335

Revenue TTM Y/Y Growth Statistics
High Average Low
31.46 %
8.11 %
-23.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 336
S&P 500 # 2333




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EHC's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Orasure Technologies Inc15.45%$ 15.445 millions
Electromed Inc 15.34%$ 15.342 millions
Irhythm Holdings Inc 15.34%$ 15.339 millions
P3 Health Partners Inc 14.80%$ 14.798 millions
Msa Safety Inc14.72%$ 14.716 millions
Ensign Group Inc14.47%$ 14.471 millions
Abbott Laboratories14.46%$ 14.460 millions
Electrocore Inc 14.40%$ 14.404 millions
Allogene Therapeutics Inc 14.29%$ 14.286 millions
Tandem Diabetes Care Inc 14.26%$ 14.257 millions
Iradimed Corporation14.15%$ 14.154 millions
Apyx Medical Corp14.09%$ 14.093 millions
Incyte Corporation14.00%$ 13.999 millions
Aurinia Pharmaceuticals Inc 13.93%$ 13.926 millions
Indivior Pharmaceuticals Inc 13.74%$ 13.738 millions
Cryoport inc 13.54%$ 13.535 millions
Neuronetics Inc 13.35%$ 13.350 millions
Royalty Pharma Plc13.26%$ 13.263 millions
Evolus Inc 13.23%$ 13.235 millions
Privia Health Group Inc 13.19%$ 13.187 millions
Biocryst Pharmaceuticals Inc 13.11%$ 13.110 millions
U S Physical Therapy Inc12.90%$ 12.898 millions
Maravai Lifesciences Holdings Inc 12.78%$ 12.781 millions
Alphatec Holdings Inc 12.67%$ 12.670 millions
Harmony Biosciences Holdings inc 12.61%$ 12.609 millions
Medicinova Inc 12.35%$ 12.355 millions
Bionano Genomics Inc 12.34%$ 12.339 millions
Viemed Healthcare Inc 12.18%$ 12.180 millions
Ufp Technologies Inc 12.15%$ 12.154 millions
Innovage Holding Corp 12.14%$ 12.135 millions


About Encompass Health Revenue Growth Rates (EHC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Encompass Health Corp (CIK 785161).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000785161-26-000239
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Encompass Health Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.